no statement of use filed
on 01 Apr 2024
Last Applicant/ Owned by
Xintai 5th Rd., Xizhi Dist.
New Taipei City
TW
221
Serial Number
97125105 filed on 15th Nov 2021
Registration Number
N/A
Correspondent Address
Joe McKinney Muncy
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
Antiviral drugs; antibiotics; antibiotics for animals; chemical reagent for medical purposes; chemical reagent for veterinary purposes; germicides for animals; germicides; biocides for medical purposes; germicide for human use; biocides for veterinary purposes; medicines for human purposes namely, for treatment of virus infection, neuropsychiatric disorders, namely, schizophrenia, depression, atte Read More
Antiviral drugs; antibiotics; antibiotics for animals; chemical reagent for medical purposes; chemical reagent for veterinary purposes; germicides for animals; germicides; biocides for medical purposes; germicide for human use; biocides for veterinary purposes; medicines for human purposes namely, for treatment of virus infection, neuropsychiatric disorders, namely, schizophrenia, depression, attention deficit disorder, mild cognitive impairment, dementia, hyperactivity, anxiety, bipolar disorder, and other central nervous system disorders; medicines for human purposes namely, for improving basic behavioral functioning, suicidal ideation and behavior, sensorimotor gating, pain threshold, memory and cognitive functioning and loss weight; sedatives; nervines for pharmaceutical or medical purposes, namely, for treating attention deficit hyperactivity disorder (ADHD), schizophrenia, pain, depression, bipolar disorder, eating disorder, addiction disorder, personality disorder, psychotic disorder, tic disorder, post-traumatic stress disorder, anxiety, social anxiety disorder, panic disorder, autism, Asperger's disorder, obsessive-compulsive disorder (OCD), learning disorder, Tourette's syndrome, mild cognitive disorder (MCI), benign forgetfulness, closed head injury, dementia, vascular dementia, Alzheimer's disorder, frontotemporal dementia, Parkinson's disorder, Huntington's disease, nocturnal enuresis, blepharospasm, non-epileptic seizure, premenstrual syndrome, and amyotrophic lateral sclerosis (ALS); gases for pharmaceutical or medical purposes, namely, for treating attention deficit hyperactivity disorder (ADHD), schizophrenia, pain, depression, bipolar disorder, eating disorder, addiction disorder, personality disorder, psychotic disorder, tic disorder, post-traumatic stress disorder, anxiety, social anxiety disorder, panic disorder, autism, Asperger's disorder, obsessive-compulsive disorder (OCD), learning disorder, Tourette's syndrome, mild cognitive disorder (MCI), benign forgetfulness, closed head injury, dementia, vascular dementia, Alzheimer's disorder, frontotemporal dementia, Parkinson's disorder, Huntington's disease, nocturnal enuresis, blepharospasm, non-epileptic seizure, premenstrual syndrome, and amyotrophic lateral sclerosis (ALS);nasal spray for treating respiratory tract infections caused by viruses or bacteria; oral spray for treating respiratory tract infections caused by viruses or bacteria
No 97125105
No Service/Collective Mark
No 5454/0213TUS
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
01st Apr 2024 | ABANDONMENT - NO USE STATEMENT FILED |
01st Apr 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
29th Aug 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
04th Jul 2023 | PUBLISHED FOR OPPOSITION |
04th Jul 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
14th Jun 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
01st Jun 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
02th May 2023 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
02th May 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
02th May 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |